Patrick Fourteau's Net Worth

$9.38 Million

Estimate Recalculated Sep 8, 2024 07:36PM EST

Who is Patrick Fourteau?

Patrick Fourteau has an estimated net worth of $9.38 Million. This is based on reported shares across multiple companies, which include FIRST HORIZON PHARMACEUTICAL CORP, Insys Therapeutics, Inc., and REPROS THERAPEUTICS INC..

SEC CIK

Patrick Fourteau's CIK is 0001235637

Past Insider Trading and Trends

2003 was Patrick Fourteau's most active year for acquiring shares with 30 total transactions. Patrick Fourteau's most active month to acquire stocks was the month of July. 2008 was Patrick Fourteau's most active year for disposing of shares, totalling 11 transactions. Patrick Fourteau's most active month to dispose stocks was the month of April. 2004 saw Patrick Fourteau paying a total of $6,899,760.00 for 308,000 shares, this is the most they've acquired in one year. In 2004 Patrick Fourteau cashed out on 400,000 shares for a total of $9,276,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

FIRST HORIZON PHARMACEUTICAL CORP No price found

Chief Executive Officer

Patrick Fourteau owns 428,291 units of Common Stock and 498,533 units of Common.acquired a total of 1,330,924 shares in FIRST HORIZON PHARMACEUTICAL CORP at a cost of $13,866,784.98, Patrick also disposed a total of 880,258 shares of FIRST HORIZON PHARMACEUTICAL CORP equalling to $20,253,317.89.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$21.37
-$2,137,390.00
498.53K
Scheduled
Aug 15
Form 4
—
0
$21.08
-$2,107,610.00
498.53K
Scheduled
May 15
Form 4
—
0
$22.45
-$1,178,373.00
498.53K
Scheduled
Feb 15
Form 4
-4.59%
-24.01K
$22.88
-$549,336.39
498.53K
Scheduled
Jan 23 - Jan 24
Form 4
-5.22%
-28.75K
$22.75
-$654,062.50
522.54K
Scheduled
Dec 7
Form 4
+28.72%
123K
$22.00
$2,706,000.00
551.29K
Dec 5
Form 4
-10.45%
-50.00K
$25.25
-$1,262,500.00
428.29K
Scheduled
Oct 31
Form 4
—
0
$24.90
-$2,490,000.00
478.29K
Scheduled
Sep 10
Form 4
—
0
$24.11
-$1,265,586.00
478.29K
Scheduled
May 16
Form 4
-3.53%
-17.50K
$23.88
-$417,830.00
478.29K
Scheduled
Jan 24
Form 4
+30.20%
115K
$23.28
$2,677,200.00
495.79K
Dec 7
Form 4
-11.61%
-50.00K
$21.70
-$1,085,130.00
380.79K
Scheduled
Nov 1
Form 4
-10.39%
-49.92K
$20.11
-$1,004,174.36
430.79K
Scheduled
Aug 1 - Aug 2
Form 4
—
0
$13.01
-$2,203,425.00
480.71K
Scheduled
May 16
Form 4
+18.30%
60K
—
—
387.92K
Jan 24
Form 4
+60.53%
200K
$14.35
$2,870,000.00
530.42K
Oct 31
Form 4
—
0
$23.19
—
330.42K
Dec 8 - Dec 10
Form 4
+2.94%
8K
$15.72
$125,760.00
280.42K
Aug 9
Form 4
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Nov 17
Form 4
+14.30%
15K
$7.16
$107,397.00
119.92K
Sep 15
Form 4
+5.00%
5K
$6.95
$34,750.00
104.92K
Sep 12
Form 4
+11.12%
10K
$6.77
$67,749.00
99.92K
Sep 11
Form 4
+12.51%
10K
$6.79
$67,900.00
89.92K
Sep 9
Form 4
+23.10%
15K
$5.47
$82,041.00
79.92K
Aug 28
Form 4
+14.46%
8.2K
$4.47
$36,684.00
64.92K
Aug 20 - Aug 21
Form 4
+13.45%
6.72K
$3.80
$25,559.68
56.72K
Aug 18 - Aug 19
Form 4
+900.00%
45K
$3.64
$163,669.30
50K
Aug 15
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Insys Therapeutics, Inc. No price found

Investor

Patrick Fourteau owns 69,682 units of Common Stock. In the year 2013 Patrick Fourteau filed a total of 21 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+16.76%
10K
$1.62
$16,200.00
69.68K
Aug 4
Form 4
+20.13%
10K
$3.63
$36,300.00
59.68K
May 26
Form 4
—
0
—
—
0
Feb 21
Form 4
-23.19%
-15.00K
$18.46
-$276,900.00
49.68K
Aug 11
Form 4
—
0
—
—
0
May 2
Form 4
-18.82%
-15.00K
$18.22
-$273,300.00
64.68K
Mar 4
Form 4
-27.35%
-30.00K
$26.48
-$794,400.00
79.68K
Nov 12
Form 4
-10.00%
-6.09K
$60.03
-$365,883.54
54.84K
May 26 - May 27
Form 4
-12.95%
-9.06K
$60.00
-$543,840.00
60.94K
May 19 - May 20
Form 4
—
0
—
—
0
May 5
Form 4
-12.50%
-10.00K
$59.94
-$599,359.00
70K
Mar 11
Form 4
-23.81%
-25.00K
$39.11
-$977,672.50
80K
Nov 19
Form 4
—
0
—
—
0
Aug 7
Form 4
+7.69%
7.5K
$22.77
$170,775.00
105K
May 15
Form 4
+8.33%
5K
$23.77
$118,850.00
65K
Aug 14
Form 4
—
0
—
—
0
May 14
Form 4
+9.09%
5K
$10.90
$54,500.00
60K
May 14
Form 4
+9.56%
4.8K
$10.90
$52,300.00
55K
May 9 - May 13
Form 4
+0.40%
200
$10.40
$2,080.00
50.2K
May 8
Form 4
∞
50K
$8.36
$418,125.00
50K
May 7
Form 3
—
0
—
—
0
No matching records found

REPROS THERAPEUTICS INC. No price found

President and CEO

Patrick Fourteau used to own units in Common Stock but no longer holds any shares there. In the year 2016 Patrick Fourteau filed a total of 6 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-40.00K
$0.67
-$26,800.00
0
Jan 29 - Jan 31
Form 4
—
0
—
—
0
Sep 15
Form 4
∞
40K
—
—
40K
Feb 13
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 12
Form 3
—
0
—
—
0
No matching records found